Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-30

Clinical Trial Update: Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates denosumab as a potential treatment option for aneurysmal bone cysts, with completed status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Bone Cyst Aneurysmal, Pathological Fracture | Phase 1, Phase 2 | Status: COMPLETED